Biogen Inc. buy Royal Bank of Canada
Start price
30.07.26
/
50%
€179.42
Target price
30.07.27
€209.52
Performance (%)
-1.88%
Price
31.07.26
€176.04
Summary
This prediction is currently active. With a performance of -1.88%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 30.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | -1.88% |
| iShares Core DAX® | 2.591% |
| iShares Nasdaq 100 | -0.915% |
| iShares Nikkei 225® | 0.145% |
| iShares S&P 500 | -0.367% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) was given a new $240.00 price target by Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat